Antoine Francis: Rethinking the Global Plasma Debate — Prioritizing Patients Over Politics
Antoine Francis, Founder of Global Plasma Supply LTD, has shared a post on LinkedIn:
“The global plasma chain is full of contradictions. Europe legislates altruism under the SoHO Regulation, but without millions of liters of paid U.S. plasma for fractionation, its patients would be left exposed. The “crowding-out” argument? No evidence. Not one death has ever been attributed to compensated plasma programs. On the contrary, where plasma is collected at scale, both paid and voluntary donations thrive side by side.
What does this tell us? That behind the debate, the ethical theatre, and the bipolar dogma, there has only ever been one measure that matters: continuity of care. Patients cannot wait.
This is why we built Global Plasma Supply LTD — not to choose sides in a false argument, but to secure plasma ethically, transparently, and at scale. Because when the medicine reaches the bedside, nobody asks whether it came from Vienna or Texas — they ask whether it arrived in time.
The debate may run circles. The lives do not.
Always think donation.
Always think life.”

Stay updated with Hemostasis Today.
-
Feb 25, 2026, 16:47Alan Nurden: Platelet Defects Explain Bleeding in EHDS Patients
-
Feb 25, 2026, 16:40Mohammed Almohammadi: Uniting Leaders in Laboratory Hematology at the 1st Saudi ISLH Joint Conference
-
Feb 25, 2026, 16:37Salihu Asimawu: Inflammation Is Not a Disease – Hats Off to the Heroes Inside Us
-
Feb 25, 2026, 16:34Michael Makris: Biomarin Has Decided to Withdraw Roctavian from the Market
-
Feb 25, 2026, 16:25Tagreed Alkaltham: The Blood Banker Personality
-
Feb 25, 2026, 16:17Sanjay Ahuja: Insightful Talk on 100 Years of VWD by Jorge Di Paola
-
Feb 25, 2026, 15:20Michael Shapiro։ Creating Real Pathways for Trainees in Preventive Cardiology
-
Feb 25, 2026, 15:15Ajay Kumar: Plasma Component Quality Control Standards
-
Feb 25, 2026, 15:09Wolfgang Miesbach: Efficacy, Safety and Thrombosis Signals in Haemophilia A/B with Inhibitors